琥乙红霉素

更新时间：2024-01-02 20:01:32

琥乙红霉素结构式	常用名	琥乙红霉素	英文名	Erythromycin Ethylsuccinate
	CAS号	1264-62-6	分子量	862.053
	密度	1.2±0.1 g/cm3	沸点	874.1±65.0 °C at 760 mmHg
	分子式	C₄₃H₇₅NO₁₆	熔点	219-224ºC
	MSDS	中文版美版	闪点	482.4±34.3 °C
	符号	GHS08	信号词	Danger

琥乙红霉素用途

Erythromycin乙基琥珀酸盐是一种抗生素,用于治疗多种细菌感染,具有与青霉素类似或稍宽于青霉素的抗菌谱。

中文名	磺胺噻唑
英文名	Erythromycin ethyl succinate
中文别名	琥乙红霉素
英文别名	更多

描述	Erythromycin乙基琥珀酸盐是一种抗生素,用于治疗多种细菌感染,具有与青霉素类似或稍宽于青霉素的抗菌谱。
相关类别	信号通路 >> 自噬 >> 自噬信号通路 >> 抗感染 >> 细菌研究领域 >> 感染

密度	1.2±0.1 g/cm3
沸点	874.1±65.0 °C at 760 mmHg
熔点	219-224ºC
分子式	C₄₃H₇₅NO₁₆
分子量	862.053
闪点	482.4±34.3 °C
精确质量	861.508606
PSA	226.28000
LogP	4.10
外观性状	白色至淡黄色结晶固体
蒸汽压	0.0±0.6 mmHg at 25°C
折射率	1.529
储存条件	2-8°C
水溶解性	ethanol: soluble50mg/mL \| Freely soluble in organic solvents, practically insoluble in water

琥乙红霉素MSDS英文版

琥乙红霉素毒性英文版

符号	GHS08
信号词	Danger
危害声明	H317-H334
警示性声明	P261-P280-P284-P304 + P340-P342 + P311
个人防护装备	dust mask type N95 (US);Eyeshields;Faceshields;Gloves
危害码 (欧洲)	Xn:Harmful
风险声明 (欧洲)	R42/43
安全声明 (欧洲)	S36
危险品运输编码	NONH for all modes of transport
WGK德国	2
RTECS号	WM9800000
海关编码	2941500000

丁二酸单乙酯酰氯

14794-31-1

红霉素

114-07-8

琥乙红霉素

1264-62-6

文献：Antibiotics Chemotherapy, , vol. 7, p. 487

琥乙红霉素上游产品 2
CAS号14794-31-1 丁二酸单乙酯酰氯 CAS号114-07-8 红霉素
琥乙红霉素下游产品 0

海关编码	2941500000

Hapten synthesis, monoclonal antibody production and development of a competitive indirect enzyme-linked immunosorbent assay for erythromycin in milk.

Food Chem. 171 , 98-107, (2014)

Erythromycin is an antibiotic used extensively in veterinary practice worldwide for treatment, prevention and growth promotion. In this work, monoclonal antibodies (Mabs) against erythromycin were pro...

Sensitive determination of tilmicosin, erythromycin ethylsuccinate and clindamycin by CE with electrochemiluminescence detection using azithromycin as internal standard and its applications.

J. Sep. Sci. 33(9) , 1305-11, (2010)

A sensitive approach for the simultaneous determination of tilmicosin, erythromycin ethylsuccinate and clindamycin was developed by CE coupled with electrochemiluminescence detection with ionic liquid...

Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.

J. Vet. Pharmacol. Ther. 31(6) , 496-500, (2008)

The purpose of this study was to describe and compare the pharmacokinetic properties of different formulations of erythromycin in dogs. Erythromycin was administered as lactobionate (10 mg/kg, IV), es...

ERYTHROMYCIN ETHYISUCCINATE

ERYTHROCINETHYLSUCCINATE

ErythromycinEthylsuccinate

Erythromycin ethylsuccinate

ERYTHROMYCIN ETHYL SUCCINATE

ERYTHROMYCIN ETHYLSUCCINATE API

(2S,3R,4S,6R)-4-(Dimethylamino)-2-{[(3S,4R,5R,6S,7S,9S,11S,12S,13R,14S)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate

ERYTHROMYCIN ETHYLSUCCINATE, ANTIBIOTIC FOR CULTURE MEDIA USE ONLY